title: Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load.
authors.forename: H
authors.initials: H
authors.lastname: Rübsamen-Waigmann
authors.forename: E
authors.initials: E
authors.lastname: Huguenel
authors.forename: A
authors.initials: A
authors.lastname: Paessens
authors.forename: J P
authors.initials: JP
authors.lastname: Kleim
authors.forename: M A
authors.initials: MA
authors.lastname: Wainberg
authors.forename: A
authors.initials: A
authors.lastname: Shah
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015331:Cohort Studies; D004311:Double-Blind Method; D004338:Drug Combinations; D004352:Drug Resistance, Microbial / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D009154:Mutation / Q000235:genetics; D010919:Placebos; D011810:Quinoxalines; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D019562:Viral Load; D014766:Viremia / Q000821:virology; D014779:Virus Replication / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents; D004338:Drug Combinations; D010919:Placebos; D011810:Quinoxalines; D018894:Reverse Transcriptase Inhibitors; C093110:HBY 097